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Environmental Tobacco Smoke
I readwith interest the article from Bermudez
et al., "Environmental Tobacco Smoke IsJust
as Damaging to DNA as Mainstream
Smoke" (EHP 102: 870-874). Environ-
mental tobacco smoke (ETS) is a complex
mixture ofchemicals resulting from dilution
in a confined environment oftobacco smoke.
ETS has three forms: 1) sidestream smoke
(SS) is produced by a cigarette during the
puffintervals, 2) mainstream smoke (MS) is
released by the smoker after smoke inhala-
tion, and 3) residual mainstream smoke
(RMS), which is a minimal proportion, slow-
ly seeps from the mouth end of a cigarette
during the puff intervals. Thus, ETS cannot
be identified by one of these components
alone. Furthermore, SS or MS determina-
tions cannot be used as a predictor of the
concentration of compounds in the ambient
air because the composition and the chemical
nature ofETS changes dramatically as it ages
and is diluted in the environment (the same
can be said regarding the prediction ofETS's
effects in terms ofpublic health). Therefore, I
was rather surprised to read that ETS is
equivalent to sidestream smoke (see the
Introduction and Material and Methods), so
the particulate matter trapped on a
Cambridge filter is equivalent to ETS "tar."
This statement is obviously untrue and delib-
erately disregards the evidence that ETS is a
dilute system compared to MS and/or SS.
The in vitro tests used to monitor the
adverse effects ofSS-derived tar trapped on a
Cambridge filter consisted of 1) rat alveolar
macrophages for the measurement of the
electron spin resonance (ESR) to detect the
presence of a persistent radical after incuba-
tion with the tar solution, 2) isolated rat thy-
mocytes incubated with the tar solution that
were then submitted to fluorescence analysis
ofDNAunwinding to determine DNAdam-
age. Both these assays gave positive results in
terms of an effect of the test material
employed. After having obtained these
results, Bermudez et al. concluded: "to our
knowledge, this is the first report ofthe DNA
nicking capability oftar from ETS" (p. 873).
I cannot agree for at least two reasons: tar was
collected from SS and not from ETS, and a
genotoxic effect ofSS tar has been known for
awhile (1,2).
In thearticle, Bermudez etal. citeworkby
Hammond et al. (3) indicating macromolecu-
lar adduction in people exposed to ETS.
Hammond et al. examined the relationship
between quantitative measurements of 4-
aminobiphenyl-hemoglobin adducts (4-
ABP-Hb) in nonsmoking, pregnant women.
Surprisingly, only one blood sample was col-
lected at delivery, and a relationship was
found between women exposed to ETS
(monitored during the third trimester of pre-
gancy by a questionnaire and by wearing a
monitor which sampled nicotine by passive
diffusion to a filter treated with sodium bisul-
fate) and the level of 4-ABP-Hb adducts
found at the time ofdelivery. The conclusion
of these authors was that the increase in the
levels of 4-ABP-Hb was not dramatic and
that thepublic health significance was unclear.
Bermudez et al. failed mention a number of
studies aimed at detecting increased levels of
DNA and hemoglobin adducts in people
exposed to ETS, all with questionable or
franklynegative outcomes (4-1J).
I would suggest repeating the alveolar
macrophage study using cells obtained by the
same technique (bronchoalveolar lavage)
from rats exposed to a real ETS environment,
controlling certain parameters: particle con-
centration, particle size, and carbon monox-
ide. This would produce much more mean-
ingful information. Alternatively, repeat the
alveolar macrophage study using trapped par-
ticulate matter carried by persons exposed to
an ETS environment and compare itwith the
material trapped by the filters obtained from
devices carried in a smoke-free environment.
Phillips et al. (11) were able to prove that, in
a confined environment where smoking was
permitted, only a median of2.5% ofthe par-
ticulate matter trapped by portable monitors
was ofETS origin.
Angelo Cerioli
Castelleone, Italy
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Assessing Chemicalsfor
Estrogenic/Hormone-Disrupting
Properties: Lessonsfrom
Carcinogenicity Assessment
Recent articles and letters in EHP(1-9) have
highlighted the growing interest in chemicals
that have the potential to mimic estrogens or
in other ways disrupt endocrine hormone bal-
ances. The specific concerns were listed suc-
cinctly in the Wingspread consensus state-
ment of 1991 (10). Any such "new" area of
toxicology poses particular problems for those
charged with assessing the safety ofindustrial
or other environmental chemicals-all chemi-
cals concomitantly come under suspicion, but
the screening assays necessary to assess this
toxic potential are usually only in the early
stages of development. As a consequence,
assay method development and chemical eval-
uations proceed in parallel, with many poten-
tial mishaps along the way. Thus, at this
moment, chemical companies and commer-
cial testing laboratories around the world face
an apparent toxicological problem of unde-
fined dimensions, but in the absence ofagreed
techniques by which to assess or solve it. In
this situation, valuable parallels are already
evident between estrogenicity testing and car-
cinogenicityprediction.
The field ofenvironmental carcinogenesis
was underpinned from the start by data on
approximately 50 discrete chemical or envi-
ronmental exposure situations in which a firm
link between chemical exposure and the
induction of cancer in humans was estab-
lished. This reference point ofstability is miss-
ing with environmental estrogens. In its place
are a range of suspected associations with
reduced human sperm counts and increases in
the incidences of human testicular, prostate,
or breast cancer. Thus, the reality or otherwise
ofa human problem will have to be evaluated
concurrently with the development of meth-
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ods and approaches to reduce, or solve, that
assumed problem. This poses unique difficul-
ties that are best recognized at the outset. In
contrast to the human situation, LeBlanc (6)
described local situations where chemical pol-
lution has been more convincingly associated
with endocrine-mediated changes in fish and
bird populations. Such effects will be capable
of rectification by local cleanup measures, as
much as enhanced industrial hygienecan rem-
edy local instances ofoccupational carcino-
genesis. The real concern to address is the
validity of the implied extrapolation from
local ecological effects to global effects on
human populations.
In common with environmental carcino-
gens, environmental estrogens will be capable
ofprediction/study using both in vitroand in
vivo assays. The initial proliferation of in
vitro techniques for the prediction ofcarcino-
genicity, and theirsubsequent culling to afew
useful assays, is well known to all. That such
a trend is happening with hormone-disrupt-
ing agents is already evident. Thus,
McLachlan (2) has described a panel of at
least nine chemical receptors that can be
linked to reporter genes and developed into
in vitroscreening tests. In addition, the use of
one or more of the available subclones of
MCF-7 cells is already being considered for
screening purposes, as discussed in EHP by
Villalobos et al. (3). In fact, Villalobos et al.
have made an early and critical contribution
to the field by establishing the problems
intrinsic to some ofthose clones. Such studies
were delayed by a decade, to general disad-
vantage, in the field of environmental car-
cinogen prediction. Obviously, a period of
assay development will be critical to this new
field, but a harmonized approach to testing,
including the recognition and unanimous
rejection ofunreliable assays, and early agree-
ment on criteria for activity in the favored
assays, will be to the common good. In the
field ofcarcinogen/ mutagen prediction, such
harmonization is being attempted at pre-
sent-probably adecade too late.
Anotherimportant generic point concerns
the different roles to be played by in vitroand
in vivo assays for hormone-disrupting activi-
ties. In the field ofmutagenesis/carcinogenesis
prediction, the Salmonella mutation assay and
itsanalogues rapidlyreplaced both the existing
and the concomitantly developed rodent
mutation assays. Eventually, however, these
rodent assays came backinto use as ameans to
distinguish which chemicals, from among the
myriad in vitrogenotoxins, were likely to pose
asignificant (actual) hazard to humans. Thus,
itwill be usefu to accept that the primary evi-
dence for an estrogenic hazard to humans
should derive from functional experiments
conducted in rodents. Villalobos et al. (3)
have noted that one such in vivo assay [the
uterine weight assay (7,8)] is not suitable for
large-scale screening, and they used that con-
dusion to introduce their in vitrostudies with
MCF-7 cells. Such is acceptable so long as a
critical role is retained for functional in vivo
assays as the final arbiters ofa possible human
hazard. Specifically, agents showing estrogenic
properties in vitro should be confirmed as
being capable of eliciting similar effects in
rodents before they are dassified as potential
estrogen mimics in humans. An additional
reason for the early consideration of in vivo
functional assays is that some chemicals may
be capable of eliciting potentially significant
hormone-disrupting effects in rodents in the
absence ofan ability to elicit estrogenic effects
in in vitro systems. Such a situation may arise
by the chemical altering the metabolism of
natural hormones, by it disrupting intratissue
hormonal control mechanisms, oras theresult
ofit being uniquely metabolized to an estro-
gen mimic in vivo. Such effects will be diffi-
cult or impossible to simulate in isolated cell
or tissuesystems. In that sense an analogymay
be drawn between pure estrogen receptor
agonists/antagonists and DNA-reactive car-
cinogens and between rodent-specific hor-
mone-disrupting chemicals and the large vari-
ety ofmechanistically distinct nongenotoxic
rodent carcinogens. If so, valuable lessons
could be learned from the maturing field of
carcinogen prediction/ assessment regarding
human risk estimation and interspecies
extrapolation oftestdata.
The greatest current problem faced by
thosewith thesafetyofchemicals in their care
is that few useful structure-activity relation-
ships (SAR) have yet been discerned forestro-
genic/hormone-disrupting agents, as noted
earlier by McLachlan (2). Thus, although
appropriate modeling may enable the struc-
ture of DDT or nonylphenol to be fitted to
the estrogen receptor, theveryfact thatchem-
icals as remotely related as kepone and nonyl
phenol can jointly be referred to as estrogen
mimics brings temporary insecurity for essen-
tiallyall organic chemicals, until, in fact, each
is established as inactive in these respects.
And again, this situation is strongly reminis-
cent of SAR in carcinogenesis. There, a sub-
family ofelectrophiles/pro-electrophiles can
be recognized, as will probably eventually
develop for pure estrogen receptor agonists/
antagonists. However, information on elec-
trophilicity does not alert to the nongenotox-
ic rodent carcinQgenicity of, for example, sac-
charin or limonene. Further, the carcino-
genicity SAR of derivatives ofsaccharin has
nothing to offer the carcinogenicity SAR of
derivatives of limonene, and vice versa.
Therefore, a precautionary recognition that
no single SAR will dominate the toxicology
of estrogenicity/hormone disruption will
probably aid the development of useful sub-
group SARs. Within such a framework, the
conclusion of McLachlan (2) that study of
the functional properties ofchemicals will be
a more productive exercise than isolated con-
sideration oftheir chemical structure/ physic-
ochemical properties is perhaps overly pes-
simistic. Thus, while it would be unwise to
seek or to rely upon simple global structural
fragments empirically associated with estro-
genic activity, detailed and model-based SAR
and quantitative SAR should prove invalu-
able within structurally coherent series of
chemicals. The latter is elegantly illustrated
by the resolving power and differential speci-
ficity ofthe quantitative SAR study ofestro-
genic chlorohydroxybiphenyls recently
reported by Waller et al. (9). The guiding
principles of predictive SAR developed for
carcinogenesis/mutagenesis have been defini-
tively reviewed by Richard (11), and most of
those principles and warnings will apply
equally to the study of estrogenic/hormone-
disruptingchemicals.
Ifsome environmental chemicals are gen-
uinely affecting human sexual development
or endocrine function, then they must be
rapidly identified and regulated. That will be
achieved most effectively ifthe basic tenets of
toxicology are accepted to apply to this new
endeavor. These tenets are that activity
observed in vitro is only indicative ofactivity
in vivo, that with rodent studies the route of
chemical exposure and the frequency of
administration ofthe test agent are often cru-
cial to the outcome of the experiment, and
that toxic potency usually varies over many
orders ofmagnitude. Finally, it is important
to note that synthetic estrogen mimics cur-
rently occupy most attention, with onlypass-
ing reference being made to their naturally
occuringanalogues. Thus, in theWingspread
statement (10,12) the balance is set at a
large number of man-made chemicals and a
few natural ones." In the field ofcarcinogen
assessment, it took over a decade to reverse a
similarpreliminary assumption (13). In sum-
mary, while attempting to respond effectively
to this new toxicological concern, we should
guard from the outset against the eventual
publication of an analogue of that seminal
paperbyAmes and Gold (13), this time enti-
tled "Too ManyRodentEstrogens."
JohnAshby
Zeneca CentralToxicology Laboratory
AlderleyPark, Cheshire, UK
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Radon Risks
Wewere delighted to have ourartide, "Effects
ofResidential Mobility on Individual versus
Population Risk of Radon-Related Lung
Cancer," published in the December issue of
EHP (103:1144-1149). In light oftwo prob-
lems, however, we thoughtyou mightappreci-
ate thefollowing feedback.
The first problem is relatively minor: we
found two typos in equations. In the second
equation on p. 1145, the subscript on Pop in
the second term after theequals sign should be
i, notj. Also, all-capital letters for variable
names were changed to lowercase letters.
Thus, our "LOG" became "log" except for the
last term in the first equation on p. 1145,
where it is "Log." (We doubt the latter will
cause anyconfusion.)
The second problem we consider more
serious. The summaryofourartide on the "In
This Issue" page (p. 1076)-never shown to
us before publication-is factually incorrect.
Our artide reports that although the popula-
tion risk ofradon is likely to be as previously
reported, the riskfacedby individualscurrently
living at high radon exposures is much less
than implied by the work ofthe EPA due to
the effects ofresidential mobility. We took
great pains to explain this quite clearly in the
article. The summary states, however, that
"Warner et al. report that estimates ofradon-
related lung cancer risks are lower than origi-
nally thought when residential mobility is
taken into account," not distinguishing
between population and individual risk. The
summary continues, incorrectly, that "Because
most people move about 10 times during their
lives, potential exposure in the 7% ofhomes
with elevated radon is actually well below lev-
els that would result in elevated risks for lung
cancer." The exposure in those homes is pre-
ciselywhat the EPAsays it is, and the cumula-
tive population risk oflung cancer associated
with people livingatthose homes is, collective-
ly, exactly what the EPA estimates (assuming
the BEIRIV model is correct, as we do). The
point is that individualscurrentlyliving in such
homes will have a lower risk because they will
move frequently throughought their lives and
hence will live at lower levels ofexposure most
or all their years. As a consequence, as we
explain the the paper, the distribution ofindi-
viduals' lifetime exposures is much more tight-
lyconcentrated aboutthemean than is thedis-
tribution ofexposures inhomes perse.
We suggest that the "In This Issue" sum-
maries be approved and.edited, as needed, by
the authors. The summary of our paper is
wrong and misleading. We haven't yet heard
from anyone confused by this, but we are dis-
appointed andconcerned.
Kenneth E.Warner
PaulN. Courant
DavidMendez
UniversityofMichigan
AnnArbor,Michigan
Erratum and Response
We apologize for any confusion that might
arise as aresult ofthe "InThis Issue" summary
ofthe paper by Dr. Warner and his co-work-
ers. We also apologize for the typographical
errors that appeared in the paper. The correct
equations are:
log(M. = -15.50 +0.92log(Popi) + 0.87
log(Pop1) -0.52log(Dist;)
ifiandjare not contiguous states, and
log(M,J = -3.09 + 0.47log(Pop) + 0.50
log(Pop ) -O.3llog(Distq)
41stAnnual Institute in Water Pollution Control
Manhattan College Riverdale, NY June 3-7, 1996
Manhattan College's forty-first annual Institute in Water Pollution Control will take place on June 3-7, 1996 in the
Manhattan College Leo Engineering Building, Riverdale, New York. Two courses, which run concurrently, will be
offered: Modern Eutrophication Modeling, and Treatment of Municipal, Hazardous and Toxic Wastewaters. These
week-long courses have much to offer young engineers and seasoned professionals who have not been able to stay
abreast of the rapidly changing field. Set in a classroom atmosphere, the courses allow for dialog between lecturer
and participants. The fee per course is $1,150 and includes a set of notes for each attendee.
For a brochure ofadditional information, contact: Ms. Lucia Chiocchio, Program Coordinator, Manhattan College,
Environmental Engineering Department, Riverdale, NY 10471.
Phone (718) 920-0277 FAX (718) 543-7914
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